Sherbrooke Park Advisers’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,006
Closed -$148K 1272
2024
Q1
$148K Buy
+10,006
New +$148K 0.03% 772